A lot of things are wrong. I presume the "secret company" (they want you to buy their research so they do not mention the company), is most probably IDBE from Canada. While Dr. Lowell's credentials are not bad, they are not "stellar". IDBE is burning cash before any major clinical tests (and vaccines because of their , that are preventative, and expected wider use require stricter tests than drugs that are ailment specifics) at the rate of $12-$15 MM annually. Not a prescription for survival. That without any single preparation having reached clinical tests of efficacy and safety. $300 MM is quite a fair valuation for such a high risk situation. As for the piece you pointed to, I don't like it, they talk in one place about the vaccines market reaching $10 Billion in 2006, forgetting about that, they then imply that each of the vaccines enabled by proteosomes will be multibillion bucks "killer drugs". Non sense. They also do not understand how vaccines, all vaccines work (for a guy that is getting a PhD in the field quite strange), he implies that the nasal route is somehow better immunologically than the blood routes, well, in the end, all vaccine work through the blood routes, antigens stimulate the immune system (which perfuse the body via the blood routes, not the nasal route) to provide future protection against the offending agent. The verbose piece made sure that I for one, will not buy their research.
Market Data 
Markets 
AI
